Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders

This publication has 65 references indexed in Scilit:

• Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic Mice
  The American Journal of Pathology, 2001
• The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
  Journal of Clinical Investigation, 1999
• Correspondence
  Atherosclerosis, 1999
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
  Nature, 1996
• N^ε-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard Reaction
  Biochemistry, 1996
• N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins
  Biochemistry, 1995
• Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic Rabbits
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
  Journal of Clinical Investigation, 1993
• Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
  Science, 1992
• The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons.
  The Journal of cell biology, 1988